ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

Evidence Links Anemia Drugs With Leukemic Transformation

December 28, 2007

DeVita Asks Panel For Help On Filling Vacancies, Object To “Effort To Get Us Back To 1970 Level”

November 21, 1980

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

Perifosine Increases PFS In Phase II Study

December 30, 2011

ASCO Strategic Plan Addresses Shortage Of Oncologists. AACR To Serve As Scientific Collaborator For Love/Avon Army of Women.

December 5, 2008